DAFNA Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

DAFNA Capital Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,000	Closed	-$307K	–	77
2018 Q2	$307K	Sell	2,000 -5,330	-73%	-$951K	0.14%	65
2018 Q1	$1.23M	Sell	7,330 -54,019	-88%	-$7.32M	0.6%	45
2017 Q4	$6M	Sell	61,349 -10,500	-15%	-$961K	3.23%	6
2017 Q3	$7.43M	Sell	71,849 -1,187	-2%	-$88.5K	4.62%	3
2017 Q2	$3.29M	Sell	73,036 -8,195	-10%	-$323K	2.35%	8
2017 Q1	$2.97M	Sell	81,231 -38,610	-32%	-$1.41M	2.52%	9
2016 Q4	$3.64M	Buy	119,841 +29,699	+33%	+$933K	3.2%	9
2016 Q3	$2.78M	Buy	90,142 +70,142	+351%	+$2.04M	1.93%	16
2016 Q2	$596K	Hold	20,000	–	–	0.47%	53
2016 Q1	$586K	Buy	+20,000	New	+$567K	0.51%	58

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DAFNA Capital Management's ONC Position: Q3 2018 in Review

DAFNA Capital Management sold out of BeOne Medicines Ltd (ONC) in Q3 2018, closing a stake of 2,000 shares — an estimated $307K sold.

DAFNA Capital Management first reported a position in ONC in Q1 2016 and held it in 10 quarters. The position peaked at $7.43M in Q3 2017. 144 funds tracked by Wall St. Rank hold ONC as of Q3 2018.

DAFNA Capital Management reported no remaining BeOne Medicines Ltd position as of Q3 2018 after selling out during the quarter.
DAFNA Capital Management sold 2,000 BeOne Medicines Ltd shares in Q3 2018, an estimated $307K.
DAFNA Capital Management first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 10 quarters.
DAFNA Capital Management's BeOne Medicines Ltd position peaked at $7.43M in Q3 2017.
144 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2018.

Based on DAFNA Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.